Cefoxitin Sodium Manufacturers
Merck & Co., Inc. is made by Cefoxitin Sodium, a second-generation cephamycin antibiotic, from Cephamycin C in the year after its discovery, 1972. It was created to generate a more broad-spectrum antibiotic. It is frequently grouped with cephalosporins of the second generation. Cefoxitin Sodium is available only with a prescription and is marketed by Bioniche Pharma, LLC under the brand name Mefoxin as of 2010. Cefoxitin Sodium is the generic name for the drug cefoxitin.
Cefoxitin Sodium injection is required to treat bacterial infections such as pneumonia and other respiratory system tract (lung) diseases, as well as infections of the urinary tract, abdomen (stomach area), women's reproductive systems, plasma, bone, joints, and skin.
The injection of Cefoxitin Sodium site may experience swelling, erythema, discomfort, or tenderness. Lack of appetite, sickness, vomiting, diarrhea, or migraine is all possible side effects of Cefoxitin Sodium medication.
Cefoxitin Sodium may impair the effectiveness of live bacterial vaccinations (such as the typhoid vaccine). Kidney function deteriorates as you age. The kidneys eliminate this medicine. As a result, elderly persons may be more susceptible to adverse effects when using Cefoxitin Sodium medication.
Although most antibiotics have little effect on hormonal birth control, such as tablets, patches, or rings, a few antibiotics (including rifampin and rifabutin) can reduce their effectiveness. This may lead to a pregnancy.
How does Cefoxitin Sodium work?
Cefoxitin Sodium is a bactericidal agent that works by preventing bacteria from forming cell walls. Cefoxitin Sodium has activity against some Gram-negative and Gram-positive bacteria's beta-lactamases, both penicillinases and cephalosporinases.
The Cost of Cefoxitin Sodium
An online search for the wholesale price for sale of Cefoxitin Sodium for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market.
Navigating our pharmaceutical marketplace
Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Cefoxitin Sodium distributor's offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and this substance Cefoxitin Sodium suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Cefoxitin Sodium. Also, each manufacturer or supplier product description contains essential information about this substance, including clinical data, stability zones, countries where Cefoxitin Sodium is already registered in. Manufacturers also have special and delivery terms.
Establishing commercial ties
If you are a pharmaceutical licensing company or a distributor, you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or Cefoxitin Sodium suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.
To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Cefoxitin Sodium Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.